ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | WebDisclosure

Basculer en Français

10159	Companies
208674	Keywords
138767	Articles
110594	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

PRESS RELEASE

published on 09/26/2025 at 07:00, 6 months 7 days ago

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise

Innovation Partnership Oncology Collaboration Immunotherapy
BRIEF

published on 09/24/2025 at 08:05, 6 months 9 days ago

OSE Immunotherapeutics Corrects Voting Rights Error Before General Meeting

Voting Rights Shareholder Meeting Accusations Material Error Proxy Firms
BRIEF

published on 09/24/2025 at 08:05, 6 months 9 days ago

OSE Immunotherapeutics corrige une erreur de droit de vote avant l'assemblée générale

Droit De Vote Assemblée Des Actionnaires Erreur Matérielle Accusations Sociétés De Procuration
PRESS RELEASE

published on 09/24/2025 at 08:00, 6 months 9 days ago

Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
OSE Immunotherapeutics corrects material error in total number of shares and voting rights, refutes accusations, and provides clarity on shareholder agreements and proxy advisory recommendations

Correction Proxy Advisory Shareholder Agreements OSE Immunotherapeutics Material Error
BRIEF

published on 09/23/2025 at 22:35, 6 months 9 days ago

OSE Immunotherapeutics répond à la décision du tribunal

Assemblée Générale Droits Des Actionnaires OSE Immunotherapeutics Tribunal De Commerce De Nantes Erreur Relative Aux Droits De Vote
BRIEF

published on 09/23/2025 at 22:35, 6 months 9 days ago

OSE Immunotherapeutics Responds to Court Decision

General Meeting Shareholder Rights OSE Immunotherapeutics Nantes Commercial Court Voting Rights Error
PRESS RELEASE

published on 09/23/2025 at 22:30, 6 months 9 days ago

OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court regarding a shareholder action and prepares for the General Meeting on September 30, 2025, ensuring transparency and commitment

Transparency General Meeting OSE Immunotherapeutics Shareholder Action Nantes Commercial Court
PRESS RELEASE

published on 09/23/2025 at 22:30, 6 months 9 days ago

OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes rejetant ses demandes. Erreur matérielle identifiée dans le calcul des droits de vote. Préparation de l'Assemblée Générale le 30 septembre 2025

Biotechnologie Assemblée Générale Tribunal De Commerce OSE Immunotherapeutics Décision
BRIEF

published on 08/29/2025 at 08:05, 7 months 5 days ago

OSE Immunotherapeutics clarifie sa stratégie face à l'activisme des actionnaires

Priorités Stratégiques OSE Immunotherapeutics Activisme Des Actionnaires Procédures Judiciaires Tedopi® Et Lusvertikimab
BRIEF

published on 08/29/2025 at 08:05, 7 months 5 days ago

OSE Immunotherapeutics Clarifies Strategy Amid Shareholder Activism

Strategic Priorities Legal Proceedings OSE Immunotherapeutics Shareholder Activism Tedopi® And Lusvertikimab

Accesswire

Published on 04/02/2026 at 22:00, 16 hours 39 minutes ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 20 hours 7 minutes ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 23 hours 39 minutes ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 23 hours 59 minutes ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/03/2026 at 14:05, 34 minutes ago

AIRSEEKERS Tron and Tron SE Series Now Available: Redefining "Real Mowing" with FlowCut™ Technology
Published on 04/03/2026 at 11:47, 2 hours 52 minutes ago

EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2026
Published on 04/03/2026 at 11:05, 3 hours 34 minutes ago

Hoymiles Bolsters European Plug-in Solar & Storage Market with HiFlow & HiFlow Pro Microinverters
Published on 04/03/2026 at 10:20, 4 hours 19 minutes ago

McDonald's Türkiye Introduces 'Archie' for Gamers
Published on 04/03/2026 at 08:55, 5 hours 43 minutes ago

EPH Group AG Secures Premium Resort Project in Vorarlberg

Les Echos

Published on 04/03/2026 at 13:29, 1 hour 10 minutes ago

Total number of voting rights and shares making up the share capital at March 31, 2026
Published on 04/03/2026 at 13:29, 1 hour 10 minutes ago

Capital et droits de vote au 31 mars 2026
Published on 04/03/2026 at 12:57, 1 hour 42 minutes ago

Mersen: Number of shares and voting rights as of March 31, 2026
Published on 04/03/2026 at 12:57, 1 hour 42 minutes ago

Mersen : nombre d'actions et de droits de vote au 31 mars 2026
Published on 04/02/2026 at 18:39, 20 hours ago

Mersen: Disclosure of trading own shares

View all LES ECHOS COMFI WIRE